AcelRx Pharmaceuticals, Inc.
(NASDAQ : ACRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -2.41%43.410.0%$446.90m
GWPHGW Pharmaceuticals Plc 0.36%214.946.1%$304.66m
VRXValeant Pharmaceuticals International, Inc. 3.39%32.9814.1%$194.06m
HZNPHorizon Therapeutics Plc 2.85%88.655.5%$177.01m
JAZZJazz Pharmaceuticals Plc 2.68%164.752.3%$175.22m
BHCBausch Health Cos., Inc. 3.39%32.980.0%$159.43m
ICLRICON plc 4.55%179.834.2%$117.77m
CTLTCatalent, Inc. 1.33%104.452.1%$101.54m
PRGOPerrigo Co. Plc 1.31%41.106.9%$81.49m
TNXPTonix Pharmaceuticals Holding Corp. 5.37%1.020.2%$59.35m
ARGXargenx SE -0.53%289.750.0%$57.97m
UTHRUnited Therapeutics Corp. 2.50%164.3414.1%$47.27m
ZYNEZynerba Pharmaceuticals, Inc. 1.47%4.156.0%$44.31m
AMRNAmarin Corp. Plc 4.72%5.991.5%$39.46m
RVMDRevolution Medicines, Inc. 7.19%45.500.0%$37.56m

Company Profile

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. Its products include sufentanil, DZUVEO, DSUVIA ZALVISO US and ZALVISO EU. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.